The merger of leading US clinical networks National Health Laboratories Holdings and Roche Biomedical Laboratories became effective on April 28th, creating the world's largest clinical laboratory with annual revenues of over $1,700 million (see Clinica No 634, p 13). President and CEO of the newly-formed LabCorp, Dr James Powell, former president of RBL, says: "Through this merger, we believe we can achieve significant economies of scale and deliver what this industry so critically needs - unprecedented efficiency."
National Health Labs, which has a 50.1% share in the new company, reported net sales of $243.8 million in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?